-
Something wrong with this record ?
Reactivation of VX-Inhibited Human Acetylcholinesterase by Deprotonated Pralidoxime. A Complementary Quantum Mechanical Study
JAV. da Silva, AF. Pereira, SR. LaPlante, K. Kuca, TC. Ramalho, TCC. França
Language English Country Switzerland
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
308225/2018-0
CAPES, CNPq - International
E-02/202.961/2017
FAPEMIG and FAPERJ - International
NLK
Directory of Open Access Journals
from 2011
PubMed Central
from 2011
Europe PubMed Central
from 2011
ProQuest Central
from 2011-01-01
Open Access Digital Library
from 2011-01-01
Open Access Digital Library
from 2011-01-01
Health & Medicine (ProQuest)
from 2011-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2011
PubMed
32012780
DOI
10.3390/biom10020192
Knihovny.cz E-resources
- MeSH
- Acetylcholinesterase chemistry drug effects MeSH
- Catalytic Domain MeSH
- Quantum Theory MeSH
- Humans MeSH
- Molecular Conformation MeSH
- Organothiophosphorus Compounds pharmacology MeSH
- Pralidoxime Compounds chemistry pharmacology MeSH
- Protons MeSH
- Serine chemistry MeSH
- Molecular Dynamics Simulation MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
In the present work, we performed a complementary quantum mechanical (QM) study to describe the mechanism by which deprotonated pralidoxime (2-PAM) could reactivate human (Homo sapiens sapiens) acetylcholinesterase (HssAChE) inhibited by the nerve agent VX. Such a reaction is proposed to occur in subsequent addition-elimination steps, starting with a nucleophile bimolecular substitution (SN2) mechanism through the formation of a trigonal bipyramidal transition state (TS). A near attack conformation (NAC), obtained in a former study using molecular mechanics (MM) calculations, was taken as a starting point for this project, where we described the possible formation of the TS. Together, this combined QM/MM study on AChE reactivation shows the feasibility of the reactivation occurring via attack of the deprotonated form of 2-PAM against the Ser203-VX adduct of HssAChE.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21012909
- 003
- CZ-PrNML
- 005
- 20210716112009.0
- 007
- ta
- 008
- 210420s2020 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/biom10020192 $2 doi
- 035 __
- $a (PubMed)32012780
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a da Silva, Jorge Alberto Valle $u Chemical, Biological, Radiological and Nuclear Defense Institute, Avenida das Americas, 28705, Guaratiba, 23020-470 Rio de Janeiro/RJ, Brazil
- 245 10
- $a Reactivation of VX-Inhibited Human Acetylcholinesterase by Deprotonated Pralidoxime. A Complementary Quantum Mechanical Study / $c JAV. da Silva, AF. Pereira, SR. LaPlante, K. Kuca, TC. Ramalho, TCC. França
- 520 9_
- $a In the present work, we performed a complementary quantum mechanical (QM) study to describe the mechanism by which deprotonated pralidoxime (2-PAM) could reactivate human (Homo sapiens sapiens) acetylcholinesterase (HssAChE) inhibited by the nerve agent VX. Such a reaction is proposed to occur in subsequent addition-elimination steps, starting with a nucleophile bimolecular substitution (SN2) mechanism through the formation of a trigonal bipyramidal transition state (TS). A near attack conformation (NAC), obtained in a former study using molecular mechanics (MM) calculations, was taken as a starting point for this project, where we described the possible formation of the TS. Together, this combined QM/MM study on AChE reactivation shows the feasibility of the reactivation occurring via attack of the deprotonated form of 2-PAM against the Ser203-VX adduct of HssAChE.
- 650 _2
- $a acetylcholinesterasa $x chemie $x účinky léků $7 D000110
- 650 _2
- $a katalytická doména $7 D020134
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a molekulární konformace $7 D008968
- 650 _2
- $a simulace molekulární dynamiky $7 D056004
- 650 _2
- $a organothiofosforové sloučeniny $x farmakologie $7 D009946
- 650 _2
- $a pralidoximové sloučeniny $x chemie $x farmakologie $7 D011220
- 650 _2
- $a protony $7 D011522
- 650 _2
- $a kvantová teorie $7 D011789
- 650 _2
- $a serin $x chemie $7 D012694
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Pereira, Ander Francisco $u Laboratory of Molecular Modeling, Chemistry Department, Federal University of Lavras, 37200-000 Lavras, MG, Brazil
- 700 1_
- $a LaPlante, Steven R $u INRS-Centre Armand-Frapier Santé Biotechnologie, 531 boulevard des Prairies, Laval, QC H7V 1B7, Canada
- 700 1_
- $a Kuca, Kamil $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, 50003 Hradec Kralove, Czech Republic
- 700 1_
- $a Ramalho, Teodorico Castro $u Laboratory of Molecular Modeling, Chemistry Department, Federal University of Lavras, 37200-000 Lavras, MG, Brazil ; Laboratory of Molecular Modeling Applied to the Chemical and Biological Defense (LMCBD), Military Institute of Engineering, Praça General Tiburcio 80, Urca, 22290-270 Rio de Janeiro/RJ, Brazil
- 700 1_
- $a França, Tanos Celmar Costa $u INRS-Centre Armand-Frapier Santé Biotechnologie, 531 boulevard des Prairies, Laval, QC H7V 1B7, Canada ; Department of Chemistry, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, 50003 Hradec Kralove, Czech Republic ; Laboratory of Molecular Modeling Applied to the Chemical and Biological Defense (LMCBD), Military Institute of Engineering, Praça General Tiburcio 80, Urca, 22290-270 Rio de Janeiro/RJ, Brazil
- 773 0_
- $w MED00188737 $t Biomolecules $x 2218-273X $g Roč. 10, č. 2 (2020)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32012780 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210420 $b ABA008
- 991 __
- $a 20210716112009 $b ABA008
- 999 __
- $a ok $b bmc $g 1651145 $s 1133288
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 10 $c 2 $e 20200127 $i 2218-273X $m Biomolecules $n Biomolecules $x MED00188737
- GRA __
- $a 308225/2018-0 $p CAPES, CNPq $2 International
- GRA __
- $a E-02/202.961/2017 $p FAPEMIG and FAPERJ $2 International
- LZP __
- $a Pubmed-20210420